-
31دورية أكاديمية
المؤلفون: Santos‐Ferreira, Diogo, Diaz, Sílvia O., Ferreira, João Pedro, Girerd, Nicolas, Pellicori, Pierpaolo, Mariottoni, Beatrice, Cosmi, Franco, Hazebroek, Mark, Verdonschot, Job A.J., Cuthbert, Joe, Petutschnigg, Johannes, Heymans, Stephane, Staessen, Jan A., Pieske, Burkert, Edelmann, Frank, Clark, Andrew L., Rossignol, Patrick, Fontes‐Carvalho, Ricardo, Cleland, John G.F., Zannad, Faiez
المصدر: ESC Heart Failure; Feb2024, Vol. 11 Issue 1, p209-218, 10p
مصطلحات موضوعية: CARDIAC patients, HEART failure, PULMONARY surfactant-associated protein D, FAILURE analysis, PLASMINOGEN activator inhibitors, ALDOSTERONE antagonists
-
32دورية أكاديمية
المؤلفون: Cooper, Trond J, Cleland, John G F, Guazzi, Marco, Pellicori, Pierpaolo, Ben Gal, Tuvia, Amir, Offer, Al-Mohammad, Abdallah, Clark, Andrew L, McConnachie, Alex, Steine, Kjetil, Dickstein, Kenneth
المساهمون: T.J. Cooper, J.G.F. Cleland, M. Guazzi, P. Pellicori, T. Ben Gal, O. Amir, A. Al-Mohammad, A.L. Clark, A. Mcconnachie, K. Steine, K. Dickstein
مصطلحات موضوعية: Exercise capacity, Heart failure, Phosphodiesterase-5 inhibitor, Pulmonary hypertension, Quality of life, Tolerability, Settore MED/11 - Malattie dell'Apparato Cardiovascolare
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35596935; info:eu-repo/semantics/altIdentifier/wos/WOS:000806213600001; volume:24; issue:7; firstpage:1239; lastpage:1248; numberofpages:10; journal:EUROPEAN JOURNAL OF HEART FAILURE; https://hdl.handle.net/2434/1006230Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85131235061
-
33دورية أكاديمية
المؤلفون: Ferreira, João Pedro, Collier, Timothy, Clark, Andrew L, Mamas, Mamas A, Rocca, Hans-Peter Brunner-La, Heymans, Stephane, González, Arantxa, Ahmed, Fozia Z, Petutschnigg, Johannes, Mujaj, Blerim, Cuthbert, Joe, Rouet, Philippe, Pellicori, Pierpaolo, Mariottoni, Beatrice, Cosmi, Franco, Edelmann, Frank, Thijs, Lutgarde, Staessen, Jan A, Hazebroek, Mark, Verdonschot, Job, Rossignol, Patrick, Girerd, Nicolas, Cleland, John G, Zannad, Faiez
المصدر: Ferreira , J P , Collier , T , Clark , A L , Mamas , M A , Rocca , H-P B-L , Heymans , S , González , A , Ahmed , F Z , Petutschnigg , J , Mujaj , B , Cuthbert , J , Rouet , P , Pellicori , P , Mariottoni , B , Cosmi , F , Edelmann , F , Thijs , L , Staessen , J A , Hazebroek , M , Verdonschot , J , Rossignol , P , Girerd , N , Cleland , J G & ....
مصطلحات موضوعية: Cardiovascular risk, Hypertension, Spironolactone, Renin, RESISTANT HYPERTENSION, TASK-FORCE, ALDOSTERONISM, PREVENTION, MANAGEMENT, FIBROSIS, IMPACT
الإتاحة: https://doi.org/10.1093/ehjcvp/pvab031Test
https://cris.maastrichtuniversity.nl/en/publications/dfc0ceee-65a3-4995-ac1e-838abd061199Test -
34دورية أكاديمية
المؤلفون: Ferreira, João Pedro, Verdonschot, Job, Girerd, Nicolas, Bozec, Erwan, Pellicori, Pierpaolo, Collier, Timothy, Mariottoni, Beatrice, Cosmi, Franco, Hazebroek, Mark, Cuthbert, Joe, Petutschnigg, Johannes, Heymans, Stephane, Staessen, Jan, A., Pieske, Burkert, Edelman, Frank, Clark, Andrew, L., Díez, Javier, González, Arantxa, Rossignol, Patrick, Cleland, John, Zannad, Faiez
المساهمون: Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Centre d'investigation clinique plurithématique Pierre Drouin Nancy (CIC-P), Centre d'investigation clinique Nancy (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists Vandoeuvre-les-Nancy (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu Nancy, Faculdade de Medicina da Universidade do Porto (FMUP), Universidade do Porto = University of Porto, Maastricht University Medical Centre (MUMC), Maastricht University Maastricht, University of Glasgow, London School of Hygiene and Tropical Medicine (LSHTM), Cortona Hospital, University of Hull United Kingdom, Charité Campus Virchow-Klinikum (CVK), German Center for Cardiovascular Research (DZHK), Berlin Institute of Health (BIH), Studies Coordinating Centre Louvain, Belgique, Catholic University of Leuven = Katholieke Universiteit Leuven (KU Leuven), Institute of Health Carlos III, Universidad de Navarra Pamplona (UNAV), European Project: 305507,EC:FP7:HEALTH,FP7-HEALTH-2012-INNOVATION-1,HOMAGE(2013)
المصدر: ISSN: 1388-9842 ; European Journal of Heart Failure ; https://hal.univ-lorraine.fr/hal-03588878Test ; European Journal of Heart Failure, 2022, ⟨10.1002/ejhf.2455⟩.
مصطلحات موضوعية: ejection fraction, fibrosis, inflammation, spironolactone, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35199421; info:eu-repo/grantAgreement/EC/FP7/305507/EU/Heart OMics in AGEing/HOMAGE; hal-03588878; https://hal.univ-lorraine.fr/hal-03588878Test; https://hal.univ-lorraine.fr/hal-03588878/documentTest; https://hal.univ-lorraine.fr/hal-03588878/file/HOMAGE_LVEF.pdfTest; PUBMED: 35199421
الإتاحة: https://doi.org/10.1002/ejhf.2455Test
https://hal.univ-lorraine.fr/hal-03588878Test
https://hal.univ-lorraine.fr/hal-03588878/documentTest
https://hal.univ-lorraine.fr/hal-03588878/file/HOMAGE_LVEF.pdfTest -
35دورية أكاديمية
المؤلفون: Kobayashi, Masatake, Girerd, Nicolas, Ferreira, João Pedro, Kevin, Duarte, Huttin, Olivier, González, Arantxa, Bozec, Erwan, Clark, Andrew, L, Cosmi, Franco, Cuthbert, Joe, Diez, Javier, Edelmann, Frank, Hazebroek, Mark, Heymans, Stephane, Mariottoni, Beatrice, Pellicori, Pierpaolo, Petutschnigg, Johannes, Pieske, Burkert, Staessen, Jan, A, Verdonschot, Job A.J., Rossignol, Patrick, Cleland, John G.F., Zannad, Faiez
المساهمون: Centre d'investigation clinique plurithématique Pierre Drouin Nancy (CIC-P), Centre d'investigation clinique Nancy (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists Vandoeuvre-les-Nancy (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu Nancy, French-Clinical Research Infrastructure Network - F-CRIN Paris (Cardiovascular & Renal Clinical Trialists - CRCT ), Universidade do Porto = University of Porto, Navarra Institute for Health Research / Instituto de Investigación Sanitaria de Navarra (IdiSNA), Universidad Pública de Navarra Espagne = Public University of Navarra (UPNA)-Universidad de Navarra Pamplona (UNAV)-Clínica Universidad de Navarra Pamplona, Institute of Health Carlos III, CIMA, University of Navarra, Castle Hill Hospital, Department of Cardiology, Cortona Hospital, Clínica Universidad de Navarra Pamplona, Charité Campus Virchow-Klinikum (CVK), German Center for Cardiovascular Research (DZHK), Berlin Institute of Health (BIH), Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Maastricht, Catholic University of Leuven = Katholieke Universiteit Leuven (KU Leuven), Institute of Health and Wellbeing, College of Medical, Veterinary and Life Sciences Glasgow, University of Glasgow-University of Glasgow, Non-Profit Research Institute Alliance for the Promotion of Preventive Medicine, Mechelen (APPREMED), The research leading to these results has received funding from the European Union Commission’s Seventh Framework programme under grant agreement N° 305507 (HOMAGE). SH acknowledge the support from the Netherlands Cardiovascular Research Initiative, an initiative with support of the Dutch Heart Foundation, Dutch Cardiovascular AllianceCVON2016-Early HFPEF, 2015-10, CVON She-PREDICTS, grant 2017-21, Furthermore, we acknowledge the support of FWO G091018N and FWO G0B5930N to S.H. AG was supported by the Instituto de Salud Carlos III (PI18/01469 co-financed by FEDER funds). SH receives personal fees for scientific advice to Astra-Zeneca, Cellprothera and CSL Behring, unrestricted research grant from Pfizer, European Project: 305507,EC:FP7:HEALTH,FP7-HEALTH-2012-INNOVATION-1,HOMAGE(2013)
المصدر: ISSN: 1388-9842 ; European Journal of Heart Failure ; https://hal.univ-lorraine.fr/hal-03696767Test ; European Journal of Heart Failure, 2022, 24 (9), pp.1559-1568. ⟨10.1002/ejhf.2579⟩.
مصطلحات موضوعية: collagen markers, myocardial fibrosis, spironolactone, diastolic function, cardiac structural remodeling, heart failure, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35703355; info:eu-repo/grantAgreement/EC/FP7/305507/EU/Heart OMics in AGEing/HOMAGE; hal-03696767; https://hal.univ-lorraine.fr/hal-03696767Test; https://hal.univ-lorraine.fr/hal-03696767/documentTest; https://hal.univ-lorraine.fr/hal-03696767/file/Echo_homage_paper.pdfTest; PUBMED: 35703355
الإتاحة: https://doi.org/10.1002/ejhf.2579Test
https://hal.univ-lorraine.fr/hal-03696767Test
https://hal.univ-lorraine.fr/hal-03696767/documentTest
https://hal.univ-lorraine.fr/hal-03696767/file/Echo_homage_paper.pdfTest -
36دورية أكاديمية
المؤلفون: Graham, Fraser J., Masini, Gabriele, Pellicori, Pierpaolo, Cleland, John G.F., Greenlaw, Nicola, Friday, Jocelyn, Kazmi, Syed, Clark, Andrew L.
وصف الملف: text
العلاقة: https://eprints.gla.ac.uk/242836/1/242836.pdfTest; Graham, F. J. , Masini, G. , Pellicori, P. , Cleland, J. G.F. , Greenlaw, N. , Friday, J. , Kazmi, S. and Clark, A. L. (2022) Natural history and prognostic significance of iron deficiency and anaemia in ambulatory patients with chronic heart failure. European Journal of Heart Failure , 24(5), pp. 807-817. (doi:10.1002/ejhf.2251 ) (PMID:34050582)
-
37دورية أكاديمية
المؤلفون: Kazmi, Syed, Kambhampati, Chandrasekhar, Cleland, John G.F., Cuthbert, Joe, Kazmi, Khurram Shehzad, Pellicori, Pierpaolo, Rigby, Alan S., Clark, Andrew L.
وصف الملف: text
العلاقة: https://eprints.gla.ac.uk/272593/1/272593.pdfTest; Kazmi, S., Kambhampati, C., Cleland, J. G.F. , Cuthbert, J., Kazmi, K. S., Pellicori, P. , Rigby, A. S. and Clark, A. L. (2022) Dynamic risk stratification using Markov chain modelling in patients with chronic heart failure. ESC Heart Failure , 9(5), pp. 3009-3018. (doi:10.1002/ehf2.14028 ) (PMID:35736536) (PMCID:PMC9715820)
-
38دورية أكاديمية
المؤلفون: Cuthbert, Joseph J., Pellicori, Pierpaolo, Clark, Andrew L.
وصف الملف: text
العلاقة: https://eprints.gla.ac.uk/285170/1/285170.pdfTest; Cuthbert, J. J., Pellicori, P. and Clark, A. L. (2022) Optimal management of heart failure and chronic obstructive pulmonary disease: clinical challenges. International Journal of General Medicine , 15, pp. 7961-7975. (doi:10.2147/IJGM.S295467 ) (PMID:36317097) (PMCID:PMC9617562)
-
39دورية أكاديمية
المؤلفون: Masini, Gabriele, Graham, Fraser J., Pellicori, Pierpaolo, Cleland, John G.F., Cuthbert, Joseph J., Kazmi, Syed, Inciardi, Riccardo M., Clark, Andrew L.
وصف الملف: text
العلاقة: https://eprints.gla.ac.uk/259126/1/259126.pdfTest; Masini, G. , Graham, F. J. , Pellicori, P. , Cleland, J. G.F. , Cuthbert, J. J., Kazmi, S., Inciardi, R. M. and Clark, A. L. (2022) Criteria for iron deficiency in patients with heart failure. Journal of the American College of Cardiology , 79(4), pp. 341-351. (doi:10.1016/j.jacc.2021.11.039 ) (PMID:35086656)
-
40دورية أكاديمية
المؤلفون: Cooper, Trond J., Cleland, John G.F., Guazzi, Marco, Pellicori, Pierpaolo, Ben Gal, Tuvia, Amir, Offer, Al‐Mohammad, Abdallah, Clark, Andrew L, McConnachie, Alex, Steine, Kjetil, Dickstein, Kenneth
وصف الملف: text
العلاقة: http://eprints.gla.ac.uk/271708/1/271708.pdfTest; Cooper, T. J. et al. (2022) Effects of sildenafil on symptoms and exercise capacity for heart failure with reduced ejection fraction and pulmonary hypertension (the SilHF study): a randomised placebo‐controlled multicentre trial. European Journal of Heart Failure , 24(7), pp. 1239-1248. (doi:10.1002/ejhf.2527 ) (PMID:35596935)